FIELD: medicine.
SUBSTANCE: invention relates to medicine, more specifically to endocrinology, cardiology and rheumatology and correction of metabolic syndrome in patients with deforming ostheoarthrosis. For this purpose in addition to traditional therapy with non-steroidal anti-inflammatory drugs and antihypertensive therapy agents, arthrofoon is sublingually administered 1 tablet four times a day, together with siofor in a dose of 500 mg 2 times a day for 12 months.
EFFECT: effective correction of metabolic and articular disorders due to synergetic effect of arthrofoon and siofor, taken in the given doses and regimes.
7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PATIENTS WITH OSTEOARTHROSIS WITH CARDIOVASCULAR DISORDERS ACCOMPANYING METABOLIC SYNDROME | 2011 |
|
RU2452534C2 |
| METHOD OF TREATING PATIENTS WITH RHEUMATOID ARTHRITIS | 2014 |
|
RU2573998C1 |
| METHOD FOR SUPPORTING TREATMENT IN LARGE JOINT REPLACEMENT | 2012 |
|
RU2527159C2 |
| METHOD FOR REHABILITATION OF PATIENTS WITH COMBINED LESION OF SPINE AND LARGE JOINS AS DUE TO PRODUCTION INJURY AT EARLY STAGE | 2016 |
|
RU2632807C1 |
| METHOD FOR TREATING PATIENTS FOR DEFORMING ARTHROSIS | 2006 |
|
RU2305572C1 |
| METHOD OF TREATING OSTEOARTHROSIS WITH UNDERLYING HYPERTENSION | 2010 |
|
RU2456030C1 |
| METHOD OF OSTEOARTHROSIS TREATMENT | 2006 |
|
RU2329024C2 |
| METHOD OF TREATING RECURRENT GONARTHRITIS | 2009 |
|
RU2400210C1 |
| METHOD OF PREDICTING RISK OF ARTERIAL HYPERTENSION DEVELOPMENT IN PATIENTS WITH PRIMARY OSTEOARTHROSIS | 2010 |
|
RU2449285C1 |
| METHOD FOR INDIVIDUAL PREVENTION OF OESTROGEN-DEPENDENT DISEASES AND REPRODUCTIVE DISORDERS IN FEMALES AT AGE OF 18-35 YEARS OLD SUFFERING METABOLIC DISORDERS | 2013 |
|
RU2527358C1 |
